Literature DB >> 23963915

Metabolomics and dereplication strategies in natural products.

Ahmed Fares Tawfike1, Christina Viegelmann, Ruangelie Edrada-Ebel.   

Abstract

Metabolomic methods can be utilized to screen diverse biological sources of potentially novel and sustainable sources of antibiotics and pharmacologically-active drugs. Dereplication studies by high resolution Fourier transform mass spectrometry coupled to liquid chromatography (LC-HRFTMS) and nuclear magnetic resonance (NMR) spectroscopy can establish the chemical profile of endophytic and/or endozoic microbial extracts and their plant or animal sources. Identifying the compounds of interest at an early stage will aid in the isolation of the bioactive components. Therefore metabolite profiling is important for functional genomics and in the search for new pharmacologically active compounds. Using the tools of metabolomics through the employment of LC-HRFTMS as well as high resolution NMR will be a very efficient approach. Metabolomic profiling has found its application in screening extracts of macroorganisms as well as in the isolation and cultivation of suspected microbial producers of bioactive natural products.Metabolomics is being applied to identify and biotechnologically optimize the production of pharmacologically active secondary metabolites. The links between metabolome evolution during optimization and processing factors can be identified through metabolomics. Information obtained from a metabolomics dataset can efficiently establish cultivation and production processes at a small scale which will be finally scaled up to a fermenter system, while maintaining or enhancing synthesis of the desired compounds. MZmine (BMC Bioinformatics 11:395-399, 2010; http://mzmine.sourceforge.net/download.shtml ) and SIEVE ( http://www.vastscientific.com/resources/index.html ; Rapid Commun Mass Spectrom 22:1912-1918, 2008) softwares are utilized to perform differential analysis of sample populations to find significant expressed features of complex biomarkers between parameter variables. Metabolomes are identified with the aid of existing high resolution MS and NMR records from online or in-house databases like AntiMarin, a merger database of Antibase (Laatsch H. Antibase Version 4.0 - The Natural Compound Identifier. Wiley-VCH Verlag GmbH & Co. KGaA, 2012) for microbial secondary metabolites as well as higher fungi and MarinLit for marine natural products (Blunt J. MarinLit. University of Canterbury, New Zealand, 2012). This is further validated through available reference standards and NMR experiments. Metabolomics has become a powerful tool in systems biology which allows us to gain insights into the potential of natural isolates for synthesis of significant quantities of promising new agents and allows us to manipulate the environment within fermentation systems in a rational manner to select a desired metabolome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963915     DOI: 10.1007/978-1-62703-577-4_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

Review 1.  The re-emergence of natural products for drug discovery in the genomics era.

Authors:  Alan L Harvey; RuAngelie Edrada-Ebel; Ronald J Quinn
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

2.  On being an honorary member of Arny's army: some musings about fungal fermentations, secondary metabolism, and scientific communities.

Authors:  Joan Wennstrom Bennett
Journal:  J Ind Microbiol Biotechnol       Date:  2017-05       Impact factor: 3.346

3.  Calothrixamides A and B from the Cultured Cyanobacterium Calothrix sp. UIC 10520.

Authors:  Camila M Crnkovic; Aleksej Krunic; Daniel S May; Tyler A Wilson; Diana Kao; Joanna E Burdette; James R Fuchs; Nicholas H Oberlies; Jimmy Orjala
Journal:  J Nat Prod       Date:  2018-09-07       Impact factor: 4.050

Review 4.  Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites.

Authors:  Brett C Covington; John A McLean; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2017-01-04       Impact factor: 13.423

5.  Biodiversity, Anti-Trypanosomal Activity Screening, and Metabolomic Profiling of Actinomycetes Isolated from Mediterranean Sponges.

Authors:  Cheng Cheng; Lynsey MacIntyre; Usama Ramadan Abdelmohsen; Hannes Horn; Paraskevi N Polymenakou; RuAngelie Edrada-Ebel; Ute Hentschel
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

6.  Metabolomic tools for secondary metabolite discovery from marine microbial symbionts.

Authors:  Lynsey Macintyre; Tong Zhang; Christina Viegelmann; Ignacio Juarez Martinez; Cheng Cheng; Catherine Dowdells; Usama Ramadam Abdelmohsen; Christine Gernert; Ute Hentschel; RuAngelie Edrada-Ebel
Journal:  Mar Drugs       Date:  2014-06-05       Impact factor: 5.118

7.  New Dimensions of Research on Actinomycetes: Quest for Next Generation Antibiotics.

Authors:  Polpass Arul Jose; Bhavanath Jha
Journal:  Front Microbiol       Date:  2016-08-19       Impact factor: 5.640

Review 8.  Discovery and resupply of pharmacologically active plant-derived natural products: A review.

Authors:  Atanas G Atanasov; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Thomas Linder; Christoph Wawrosch; Pavel Uhrin; Veronika Temml; Limei Wang; Stefan Schwaiger; Elke H Heiss; Judith M Rollinger; Daniela Schuster; Johannes M Breuss; Valery Bochkov; Marko D Mihovilovic; Brigitte Kopp; Rudolf Bauer; Verena M Dirsch; Hermann Stuppner
Journal:  Biotechnol Adv       Date:  2015-08-15       Impact factor: 14.227

9.  Metabolomic profiling and genomic study of a marine sponge-associated Streptomyces sp.

Authors:  Christina Viegelmann; Lekha Menon Margassery; Jonathan Kennedy; Tong Zhang; Ciarán O'Brien; Fergal O'Gara; John P Morrissey; Alan D W Dobson; RuAngelie Edrada-Ebel
Journal:  Mar Drugs       Date:  2014-06-02       Impact factor: 5.118

10.  In Search of Alternative Antibiotic Drugs: Quorum-Quenching Activity in Sponges and their Bacterial Isolates.

Authors:  Kumar Saurav; Rinat Bar-Shalom; Markus Haber; Ilia Burgsdorf; Giorgia Oliviero; Valeria Costantino; David Morgenstern; Laura Steindler
Journal:  Front Microbiol       Date:  2016-04-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.